Every day, hundreds of scientists are generating, analyzing and managing clinical plans to develop new drugs that patients are waiting for. The pediatric strategy plan forms the building blocks of the regulatory road map and its quality is critical to crucial business decisions and long term success.
KinderPharm invites you to take an in-depth look into potential risks in your pediatric strategy plan. We will explore ways to minimize the number of children enrolled in clinical trials while providing high quality data to support pediatric labelling, creating a significant cost savings.
Contact Alberto Bryan at 610-458-1051 x330 to schedule a call.